APA (7th ed.) Citation

Y, L., Y, G., X, H., Q, W., Y, W., H, Y., . . . W, S. (2026). The splicing factor hnRNPA1 promotes osimertinib resistance in lung adenocarcinoma by regulating NEDD4L alternative splicing. Oncogene, 45(30), 3039. https://doi.org/10.1038/s41388-026-03854-1

Chicago Style (17th ed.) Citation

Y, Liang, et al. "The Splicing Factor HnRNPA1 Promotes Osimertinib Resistance in Lung Adenocarcinoma by Regulating NEDD4L Alternative Splicing." Oncogene 45, no. 30 (2026): 3039. https://doi.org/10.1038/s41388-026-03854-1.

MLA (9th ed.) Citation

Y, Liang, et al. "The Splicing Factor HnRNPA1 Promotes Osimertinib Resistance in Lung Adenocarcinoma by Regulating NEDD4L Alternative Splicing." Oncogene, vol. 45, no. 30, 2026, p. 3039, https://doi.org/10.1038/s41388-026-03854-1.